Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127762411 | 12776241 | 1 | I | 201606 | 20160919 | 20160923 | 20160923 | EXP | ID-BAYER-2016-182188 | BAYER | 0.00 | M | Y | 0.00000 | 20160923 | CN | ID | ID |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127762411 | 12776241 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 2 X 200 MG, WEEK 1 AND 2 | 21923 | 400 | MG | FILM-COATED TABLET | |||||||
| 127762411 | 12776241 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 3 X 200 MG, WEEK 3 AND 4 | 21923 | 600 | MG | FILM-COATED TABLET | |||||||
| 127762411 | 12776241 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 3 X200 MG WEEK 1 AND 2 FROM 4TH MONTH | 21923 | 600 | MG | FILM-COATED TABLET | |||||||
| 127762411 | 12776241 | 4 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 2 X 200 MG WEEK 3 AND 4 | 21923 | 400 | MG | FILM-COATED TABLET | |||||||
| 127762411 | 12776241 | 5 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 3 X 200 MG FROM 5TH MONTH | 21923 | 600 | MG | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127762411 | 12776241 | 1 | Hepatocellular carcinoma |
| 127762411 | 12776241 | 2 | Metastases to lymph nodes |
| 127762411 | 12776241 | 3 | Hepatocellular carcinoma |
| 127762411 | 12776241 | 4 | Hepatocellular carcinoma |
| 127762411 | 12776241 | 5 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127762411 | 12776241 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127762411 | 12776241 | Gait disturbance | |
| 127762411 | 12776241 | Hepatocellular carcinoma | |
| 127762411 | 12776241 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127762411 | 12776241 | 1 | 201605 | 0 | ||
| 127762411 | 12776241 | 3 | 201606 | 0 |